Compare Lee's Pharmaceutical Holdings Ltd. with Similar Stocks
Dashboard
1
With ROE of 11.94%, it has a Very Attractive valuation with a 0.30 Price to Book Value
- Over the past year, while the stock has generated a return of -23.45%, its profits have risen by 6.8% ; the PEG ratio of the company is 0.4
- At the current price, the company has a high dividend yield of 436.9
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.11%
0%
-13.11%
6 Months
-34.97%
0%
-34.97%
1 Year
-30.26%
0%
-30.26%
2 Years
-7.02%
0%
-7.02%
3 Years
-27.89%
0%
-27.89%
4 Years
-49.52%
0%
-49.52%
5 Years
-76.75%
0%
-76.75%
Lee's Pharmaceutical Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.55%
EBIT Growth (5y)
13.25%
EBIT to Interest (avg)
74.18
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.44
Tax Ratio
21.23%
Dividend Payout Ratio
28.83%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
26.07%
ROE (avg)
16.32%
Valuation key factors
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.30
EV to EBIT
2.47
EV to EBITDA
2.32
EV to Capital Employed
0.28
EV to Sales
0.56
PEG Ratio
0.37
Dividend Yield
436.89%
ROCE (Latest)
11.36%
ROE (Latest)
11.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Dec 2017
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'17 - YoY
Dec'17
Dec'16
Change(%)
Net Sales
258.80
231.20
11.94%
Operating Profit (PBDIT) excl Other Income
45.30
72.40
-37.43%
Interest
0.90
1.00
-10.00%
Exceptional Items
-1.60
-0.70
-128.57%
Consolidate Net Profit
47.20
52.70
-10.44%
Operating Profit Margin (Excl OI)
174.90%
313.30%
-13.84%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2017 is 11.94% vs 9.06% in Dec 2016
Consolidated Net Profit
YoY Growth in quarter ended Dec 2017 is -10.44% vs -12.46% in Dec 2016
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,436.00
1,400.00
2.57%
Operating Profit (PBDIT) excl Other Income
217.10
221.00
-1.76%
Interest
11.20
14.20
-21.13%
Exceptional Items
-16.20
-26.30
38.40%
Consolidate Net Profit
50.60
68.60
-26.24%
Operating Profit Margin (Excl OI)
42.80%
52.30%
-0.95%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.57% vs 32.95% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -26.24% vs 244.72% in Dec 2024
About Lee's Pharmaceutical Holdings Ltd. 
Lee's Pharmaceutical Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






